Status:
UNKNOWN
VITAMin Insufficiency in Esophagogastric Neoplasms
Lead Sponsor:
Zuyderland Medisch Centrum
Conditions:
Esophageal Cancer
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Esophageal cancer and gastric cancer are among the top ten most common cancers worldwide. Both diseases have major impact on the nutritional status of patients and their quality of life. St...
Eligibility Criteria
Inclusion
- A potential subject who meets any of the following criteria will be included for participation in this study:
- Patients ≥18 years of age who underwent an esophagectomy or (sub)total gastrectomy for malignancy with no signs of postoperative recurrence of disease.
- Written voluntary informed consent (IC).
Exclusion
- \-
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients that underwent a wedge resection of the stomach
- Malignant disease recurrence
- Metastases
- Patients that are not capable to take supplementation due to altered mental status or swallow difficulties
- No signed informed consent
- Patients who are receiving chemotherapy
- Patients with high vitamin status at baseline
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT05281380
Start Date
December 1 2021
End Date
November 1 2024
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ZuyderlandMC
Sittard, Limburg, Netherlands, 6130MB